CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market buy Chief Executive Officer bought 3,250 shares at $6.01 ($19,539)
- 4 Open-market buy Chief Medical Officer bought 4,233 shares at $9.49 ($40,171)
- 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $9.60 ($19,200)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $7.20 ($10,800)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $7.75 ($7,750)
- 4 Open-market buy Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)
- 4 Open-market buy Director bought 1,000 shares at $7.49 ($7,490)
- 4 Open-market buy Director bought 2,000 shares at $7.55 ($15,100)
- 4 Open-market buy Director bought 10,000 shares at $7.00 ($69,960)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 17 · 340 filings